Artwork
iconShare
 
Manage episode 478467424 series 2965879
Content provided by Rizwan Chaudhrey. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Rizwan Chaudhrey or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://staging.podcastplayer.com/legal.

I sat down last week with ScaleReady's Global Director Commercial Operations, Josh Ludwig to get thoughts on the past 12 months and get some predictions for 2023.
I asked Josh...
• How was Phacilitates Advanced Therapies Week? 00:49
2022 Reflections
• Can you give me a quick overview of ScaleReady? 01:29
• One word to describe 2022 and why? 02:53
• What were some of ScaleReady's key achievements in 2022? 04:49
• Looking back at 2022 what challenges did you see the sector face, and developments stood out for you? 07:56
• Are there any areas you think the industry could improve? 10:28
2023 Forecasts
• What are your predictions for the Life Sciences and BioPharma in 2023? 12:53
• How will Sustainability and AI impact ATMP and Cell Therapy sector? 14:52
• What can we expect from ScaleReady in 2023? 20:04
• Will ScaleReady be looking for partners to cooperate with in 2023? 22:39
• Finally, what last thoughts would you like to leave viewers with for 2023? 25:14
🎞 WATCH the interview here https://lnkd.in/erpxwfUh
Feel free to leave Josh any comments and questions below.
You can meet Josh and the team at ScaleReady at numerous events throughout he year, including this months CAR-TCR Summit Europe at the Excel in London, and learn more at www.ScaleReady.com

  continue reading

75 episodes